Acute Myeloid Leukemia: Incorporating Novel Treatment Approaches into Clinical Pathways

0 Views
administrator
administrator
07/04/23

Earn CME for related activities: https://www.naccme.com/oln

This on-demand webcast examines the latest clinical and pharmacoeconomic data surrounding emerging therapies in AML, including novel chemotherapy formulations, FLT3 inhibitors, and IDH inhibitors for informed pathway placement.

ยฉ 2018 NACCME, an HMP Company

Show more

0 Comments Sort By

No comments found

Facebook Comments

Up next